An Observational Study of Reduction in Glycemic Parameters and Liver Stiffness by Saroglitazar 4 mg in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
2019 ◽
Vol 39
(7)
◽
pp. 631-641
◽
2017 ◽
Vol 13
(3)
◽
pp. 150-156
◽
2018 ◽
Vol 22
(3)
◽
pp. 421
◽